BIIB News 295.85 05/14/2014 04:32:02 Biogen Idec Inc (BIIB)

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Biogen Idec Inc (BIIB) 295.85 $BIIB

Is Isis Pharmaceuticals, Inc. Now a Bargain?
George Budwell, The Motley Fool - Motley Fool - Tue May 13, 11:31AM CDT
Isis Pharmaceuticals has one heck of a bad year in terms of the performance of its share price, falling close to 40% year-to-date. And starting in late February, the stock has essentially made a beeline lower. Given the dramatic and rapid nature of...

SmarTrend Watching for Potential Pullback in Shares of Biogen Idec After 4.85% Gain
Comtex SmarTrend(R) - Mon May 12, 3:59PM CDT
Biogen Idec (NASDAQ:BIIB) traded in a range yesterday that spanned from a low of $288.01 to a high of $301.00. Yesterday, the shares gained 4.8%, which took the trading range above the 3-day high of $291.28 on volume of 1.7 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.

Cisco Powers Up as Dow Races to Hundred-Point Gain
Dan Carroll, The Motley Fool - Motley Fool - Mon May 12, 1:35PM CDT
Stocks have raced higher to start the new week, with the Dow Jones Industrial Average jumping out of the starting gate at the bell and rising 110 points as of 2:30 p.m. EDT.  Most blue-chip stocks on the index are in the green. Tech giant Cisco ...

Technical Coverage on Biotech Stocks -- Research on Athersys, Lexicon Pharma, Biogen Idec, and Theravance
PR Newswire - Mon May 12, 11:30AM CDT
On Friday, May 09, 2014, the NASDAQ Composite ended at 4,071.87, up 0.50%, the Dow Jones Industrial Average finished the day 0.20% higher at 16,583.34, and the S&P 500 closed at 1,878.48, up 0.15%. The gains were broad based as six out of ten sectors ended the session in positive. The S&P 500 Health Care Sector Index ended the day at 668.35, up 0.58%, and the index has advanced 3.66% in the last one month. Investor-Edge has initiated coverage on the following equities: Athersys Inc. (NASDAQ: ATHX), Lexicon Pharmaceuticals Inc. (NASDAQ: LXRX), Biogen Idec Inc. (NASDAQ: BIIB) and Theravance Inc. (NASDAQ: THRX). Free technical research on ATHX, LXRX, BIIB and THRX can be downloaded upon signing up at:

Post Earnings Update: Biogen Idec Has Sunk 6.6% Lower in Past 2 Weeks (BIIB)
Comtex SmarTrend(R) - Mon May 12, 10:58AM CDT
When Biogen Idec (NASDAQ:BIIB) reported earnings 19 days ago on April 23rd, 2014, analysts, on average, expected the company to report earnings of $2.56 on sales of $2.0 billion. The company actually reported EPS of $2.47 on sales of $2.1 billion, missing EPS estimates by $0.08 and beating revenue estimates by $126.2 million. Shares of Biogen Idec have slipped from $306.75 to $286.65, representing a loss of 6.6%, since the company reported earnings 19 days ago.

Visualizing Biotech P/E Compression and Why It's a Buy Signal
at The Street - Mon May 12, 9:19AM CDT
J.P. Morgan analyst Geoff Meacham issued a cautiously optimistic note about the biotech sector this morning. While investor sentiment remains "fragile," and volatility continues to be high, Meacham believes the worst of the selling is over.

2014 FDA Drug Approval Calendar
at The Street - Mon May 12, 8:22AM CDT
A list of drugs under FDA review and scheduled FDA advisory panel meetings.

Richard A. Rudick Joins Biogen Idec as Vice President, Development Sciences, Value-Based Medicine
Business Wire - Mon May 12, 6:00AM CDT
Biogen Idec (NASDAQ: BIIB) today announced that Richard (Rick) A. Rudick, M.D., has joined the company as vice president, Development Sciences, Value-Based Medicine.

Biogen Idec and Sobi to donate 1 billion international units of clotting factor to support treatment of haemophilia in developing world
Thomson Reuters ONE - Mon May 12, 1:19AM CDT
- World Federation of Hemophilia Humanitarian Aid Program to Receive 500 Million International Units Over 5 Years -

Biogen Idec and Sobi to Donate 1 Billion International Units of Clotting Factor to Support Treatment of Hemophilia in Developing World
Business Wire - Mon May 12, 1:00AM CDT
Biogen Idec (NASDAQ:BIIB) and Swedish Orphan Biovitrum AB (publ) (Sobi) (STO:SOBI) today announced their intent to produce one billion international units (IUs) of clotting factor therapy for humanitarian aid programs in the developing world at the World Federation of Hemophilia (WFH) 2014 World Congress. Initially, the companies have committed to donating up to 500 million IUs to the World Federation of Hemophilia over five years to support its efforts to raise the standard of care for people with hemophilia in the developing world. The remaining 5000 million IUs of clotting factor will be made available for future distribution.

3 Drugs Set to Become Blockbusters in 2014
Todd Campbell, The Motley Fool - Motley Fool - Sun May 11, 10:30AM CDT
Blockbuster status, an unofficial gold medal awarded to therapies racking up sales of $1 billion or more per year, is the holy grail for drug developers. Arguably, it's the chance to discover blockbusters that fuel industry R&D spending and...

Infinity Pharma Down on Wider-than-Expected Loss - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu May 08, 4:20PM CDT
Infinity Pharma (INFI) reported a loss of 87 cents per share in the first quarter of 2014, wider than the Zacks Consensus Estimate of a loss of 80 cents.

Investor's Corner: How To Use The Big Cap 20
at Investor's Business Daily - Thu May 08, 3:09PM CDT
As IBD stock screens go, the IBD Big Cap 20 is of a different stripe. A primary focus on large-capitalization stocks distinguishes it from the high-growth slant of the IBD 50 or Your Weekly Review. But that doesn't mean that the IBD Big Cap 20, which...

Biogen Idec to Present at the Bank of America Merrill Lynch 2014 Health Care Conference
Business Wire - Thu May 08, 3:01PM CDT
Biogen Idec Inc. (NASDAQ: BIIB) announced today that it will present at the Bank of America Merrill Lynch 2014 Health Care Conference. The webcast will be live on Wednesday, May 14, 2014 at 5:00 p.m. PT, 8:00 p.m. ET. To access the live webcast, please visit Biogen Idec's Investors section at www.biogenidec.com. An archived version of the webcast will be available for 14 days following the presentation.

Narrower-than-Expected Loss at AVEO - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu May 08, 8:20AM CDT
AVEO Pharmaceuticals, Inc. (AVEO) reported a first-quarter 2014 loss of 5 cents per share (excluding one-time expenses).

Is Sunesis Pharmaceuticals Poised for a Breakout?
George Budwell, The Motley Fool - Motley Fool - Thu May 08, 5:51AM CDT
So far this year, we've seen a handful of developmental-stage oncology companies report positive late-stage data for their therapeutic candidates, resulting in major rallies in their respective share prices. For example, Endocyte , InterMune , and...

Isis Pharma's Q1 Loss Widens - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed May 07, 3:30PM CDT
Isis Pharma (ISIS) reported wider-than-expected loss in the first quarter of 2014.

AVEO Oncology Reports First Quarter 2014 Financial Results
Business Wire - Wed May 07, 3:15PM CDT
AVEO Oncology (NASDAQ:AVEO) today reported its first quarter 2014 financial results and provided an update on its progress toward achieving its strategic plan.

Acorda Misses on Earnings, Beats Revs - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed May 07, 12:43PM CDT
Acorda Therapeutics, Inc.'s (ACOR) first quarter earnings of 2 cents per share missed the Zacks Consensus Estimate of 4 cents.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Scientific Games Takes Big Buck Hunter to Lotteries

Updated Category News Views 84

A mounted arcade cabinet is an odd place to find lottery growth, yet Scientific Games may be onto something with its exclusive Big Buck Hunter licensing deal. Announced November 19, 2026, the arrangement lets the company carry a 26-year-old arcade franchise into U.S. and Canadian instant scratch games, Fast Play, draw games, digital products and second-chance promotions....

Continue Reading
CCTV-4 Revisits China's Enduring Academy Tradition

Updated Category News Views 57

Stone courtyards, old books and hard questions are getting prime time on CCTV-4, which is a more interesting programming bet than it may first appear. Enduring Chinese Academies, a ten-episode cultural exploration series from China Media Group's Global Chinese Programming Center, is built around a simple theme: “One academy, one spirit.” It begins airing November 22...

Continue Reading
Live Nation Tests Creator Content With Morgan Jay Series

Updated Category News Views 157

A comedian turning crowd work into songs is hardly a boardroom event, but this one has a useful wrinkle: Live Nation Studios put financing behind it. Morgan Jay and Austin-based agency Hello Party launched Music Therapy with Morgan Jay on YouTube on November 18, with Kam Patterson opening the season. The show pairs Jay and celebrity guests for loose conversation,...

Continue Reading
Eight O'Clock Adds Blonde Roast Pods to Its Lineup

Updated Category News Views 166

A lighter cup of coffee just became Eight O'Clock Coffee's newest swing at the single-serve shelf. On Nov. 19, 2026, the company said it introduced Blonde Roast K-Cup pods, a bright and smooth option aimed at drinkers who prefer a lighter roast. The product is available through Keurig.com and Amazon. That is the whole announcement, and frankly it is better to keep it that...

Continue Reading
CMA Wins Spotlight Greenberg Traurig’s Music Bench

Updated Category News Views 119

Four trophies on one awards night can say plenty about the machinery behind a music career, even if nobody should confuse a CMA acceptance speech with a balance-sheet event. Greenberg Traurig’s entertainment practice is celebrating client wins at the 60th annual CMA Awards, held Nov. 18, 2026: three honors tied to Miranda Lambert and one for Brooks & Dunn. For investors...

Continue Reading
SDG&E's 21-Year Reliability Run Has Real Investor Weight

Updated Category News Views 56

Seventy minutes without power in a year is the sort of number most people ignore until their refrigerator quits humming. For San Diego Gas & Electric customers, though, it is a meaningful operating result: roughly 70 minutes annually from unplanned outages, on average, over the past decade, alongside fewer than one sustained outage per customer each year. SDG&E has also...

Continue Reading
BreakBio's New CSO Adds Vaccine Trial Credibility in Cancer

Updated Category News Views 144

Personalized cancer vaccines have no shortage of grand promises; seasoned clinical operators are the rarer commodity. That is why BreakBio's appointment of Dr. Greg Lizée as chief scientific officer deserves a closer look, even if nobody should confuse an executive hire with clinical validation. BreakBio is private, its lead program remains in development, and cancer...

Continue Reading
Clickstop's Urbana Expansion Bets on Durable Demand

Updated Category News Views 81

A patch of turned Iowa dirt can say plenty about a company’s nerve. Clickstop broke ground in Urbana on Nov. 19, 2026, for a 43,000-square-foot building, and the message is pretty plain: management believes its recent growth has legs. For a privately held, employee-owned operator serving trucking, construction, lifting and rigging, that is not a casual decision....

Continue Reading
Zensar’s AI Forum Puts Operations Before the AI Hype

Updated Category News Views 47

Johannesburg’s AI conversation seems to be shedding its costume jewelry at last. Zensar’s invitation-only CIS Converge 2026 forum, held on November 20, put the attention where it belongs: not on breathless demos, but on whether companies can turn AI into sturdier operations, better customer experiences, and something resembling a measurable return. That is a healthier...

Continue Reading
HLRBO's Data-Heavy Rebuild Changes Hunting Lease Market

Updated Category News Views 149

A hunting lease used to begin with hearsay, blurry photos, and a whole lot of hoping. HLRBO is trying to drag that stubbornly analog process into a data-rich, phone-first marketplace, and frankly, it is about time. The company rebuilt its web and mobile platforms around parcel information, plain-language AI search, mobile lease completion, and its Land IQ™ scoring...

Continue Reading

Top 5 Most Recently Viewed Articles

Jeff Ettinger Returns to Hormel Foods Board Leadership Today

Updated Category News Views 219

Jeff Ettinger Returns to Hormel Foods Board Leadership Today Hormel Foods Corporation (NYSE: HRL), a leading global branded food company, recently announced the reappointment of Jeff Ettinger to its Board of Directors. With extensive experience in the food industry, including nearly three decades at Hormel, Ettinger's appointment marks an important step for the company....

Continue Reading
NEXGEL Welcomes Finance Expert Steve Ciardiello to Board

Updated Category News Views 238

NEXGEL Welcomes New Board Member for Growth and Innovation NEXGEL, Inc. (NASDAQ: NXGL), a prominent provider of medical and over-the-counter (OTC) products, has announced a significant addition to its Board of Directors. The company has appointed Steve Ciardiello, CPA, currently the Chief Accounting Officer of Shutterstock, Inc. (NYSE: SSTK), to its board. This decision...

Continue Reading
Exploring Bitcoin's Potential to Reach $200,000 by 2025

Updated Category News Views 250

Bernstein’s 2025 Bitcoin Target In an insightful report, analysts from Bernstein set forth ambitious predictions for Bitcoin, speculating that the price could soar to $200,000 by the end of 2025. This forecast stems from increasing institutional interest and Bitcoin's inherently limited supply, factors which highlight its potential as a premier store of value. “As...

Continue Reading
Innovent Launches First Patient Dosing for New DME Treatment

Updated Category News Views 256

Innovent's Groundbreaking Clinical Study Begins Innovent Biologics, Inc. (HKEX: 01801) has marked a significant milestone in ophthalmic therapy with the initiation of first patient dosing in a Phase 2 clinical study focusing on efdamrofusp alfa (IBI302). This innovative treatment represents a first-in-class bispecific fusion protein specifically designed to address...

Continue Reading
Arrow Tool Group Taps Hong to Drive Growth Strategy

Updated Category News Views 42

Big Moves at Arrow Tool Group There's a new sheriff in town at Arrow Tool Group, folks. Say hello to Chee Min Hong, the newly minted Vice President of Product Management, eCommerce & Brand Marketing. From what I gather, this isn't Hong's first rodeo. Having spent over 25 years wrangling product portfolios and fine-tuning brand strategies for giants like MANSCAPED and...

Continue Reading